CX3CL1 and rheumatoid arthritis: Studies also suggested that fractalkine stimulates cells growth in rheumatoid arthritis-fibroblast-like synoviocytes (RA-FLS) and that an NF-κB pathway blocker inhibits fractalkine, thus promoting the proliferation of RA-FLS.